All text is © British Library Board and is available under a Creative Commons Attribution Licence, except where otherwise stated.
Explore the British Library
6 results for Everything in this catalogue
Sort by:
Sort by:
relevanceOr hit Enter to replace sort method
- relevance
- date-newest
- date-oldest
- Title
- Author
Refined by:
publisher:
Taylor & Francis
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Healthcare resource utilization and costs associated with herpes zoster in the USJohnson, Barbara H. et al.Journal of medical economics. Volume 19:Issue 10 (2016, October); pp 928-935 -- Taylor & FrancisOnline access |
| 2 |
Material Type: Article
|
|
Healthcare resource utilization and costs associated with herpes zoster in the USJohnson, Barbara H. et al.Journal of medical economics. Volume 19:Number 10 (2016); pp 928-935 -- Taylor & FrancisOnline access |
| 3 |
Material Type: Article
|
|
Safety and immunogenicity of VAQTA® in children 12-to-23 months of age with and without administration of other US pediatric vaccinesPetrecz, Maria et al.Human vaccines & immunotherapeutics. Volume 15:Issue 2 (2019); pp 426-432 -- Landes Bioscience -- Taylor & FrancisOnline access |
| 4 |
Material Type: Article
|
|
Safety and immunogenicity of VAQTA® in children 12-to-23 months of age with and without administration of other US pediatric vaccinesPetrecz, Maria et al.Human vaccines & immunotherapeutics. Volume 15:Number 2 (2019, February 1st); pp 426-432 -- Taylor & FrancisOnline access |
| 5 |
Material Type: Article
|
|
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adultsStacey, Helen L. et al.Human vaccines & immunotherapeutics. Volume 15:Number 3 (2019, March 4th); pp 530-539 -- Taylor & FrancisOnline access |
| 6 |
Material Type: Article
|
|
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adultsStacey, Helen L. et al.Human vaccines & immunotherapeutics. Volume 15:Issue 3 (2019); pp 530-539 -- Landes Bioscience -- Taylor & FrancisOnline access |
Refine Search Results
Refine my results
Access Options
Author/Contributor
- Klopfer, Stephanie O. (2)
- Kosinski, Michael (2)
- Peterson, James T. (2)
- Benner, Patrice (2)
- Musey, Luwy K. (2)
- Stacey, Helen L. (2)
- Nolan, Katrina M. (2)
- Pujar, Hari (2)
- Williams-Diaz, Angela (2)
- Gatwood, Justin (2)
- Schödel, Florian P. (2)
- Sterling, Tina M. (2)
- Lee, Andrew W. (2)
- Kawai, Kosuke (2)
- Palmer, Liisa (2)
- Li, Jianing (2)
- Rosen, Jeffrey (2)
- Johnson, Barbara H. (2)
- Smith, William J. (2)
-
Refine further
Subject
- Vaccines--Periodicals (4)
- Herpes zoster--PHN--healthcare resource utilization and costs--case control--administrative claims data--immunocompetent population (2)
- Medical care--Cost control--Periodicals (2)
- safety--immunogenicity--hepatitis A vaccine--integrated analyses (2)
- pneumococcal conjugate vaccine--safety--immunogenicity (2)
- Medical economics--Periodicals (2)
-
Refine further